APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 78 filers reported holding APPLIED MOLECULAR TRANS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $914 | -72.8% | 5,825 | -55.2% | 0.00% | – |
| Q2 2023 | $3,356 | -97.6% | 13,009 | -97.0% | 0.00% | – |
| Q1 2023 | $140,434 | +2816.0% | 438,859 | +3728.1% | 0.00% | – |
| Q4 2022 | $4,816 | -98.8% | 11,464 | -97.2% | 0.00% | – |
| Q3 2022 | $398,000 | -87.0% | 408,775 | -61.2% | 0.00% | – |
| Q2 2022 | $3,062,000 | -59.8% | 1,052,323 | +4.0% | 0.00% | -100.0% |
| Q1 2022 | $7,611,000 | -0.1% | 1,012,159 | +85.8% | 0.00% | 0.0% |
| Q4 2021 | $7,618,000 | +38.6% | 544,896 | +156.4% | 0.00% | 0.0% |
| Q3 2021 | $5,497,000 | +585.4% | 212,484 | +1110.9% | 0.00% | – |
| Q2 2021 | $802,000 | +171.9% | 17,548 | +161.7% | 0.00% | – |
| Q1 2021 | $295,000 | -91.2% | 6,706 | -93.8% | 0.00% | -100.0% |
| Q4 2020 | $3,349,000 | +2074.7% | 108,836 | +2148.2% | 0.00% | – |
| Q3 2020 | $154,000 | – | 4,841 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ Capital Group, LLC | 9,098,780 | $68,423,000 | 18.70% |
| Founders Fund VI Management, LLC | 826,607 | $6,216,000 | 10.49% |
| Founders Fund V Management, LLC | 3,611,615 | $27,159,000 | 1.74% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 320,000 | $2,406,000 | 0.20% |
| Avoro Capital Advisors LLC | 1,030,000 | $7,746,000 | 0.14% |
| Burleson & Company, LLC | 73,803 | $555,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 71,073 | $534,000 | 0.07% |
| Virtus ETF Advisers LLC | 11,621 | $87,000 | 0.04% |
| EcoR1 Capital, LLC | 131,693 | $990,000 | 0.03% |
| Trexquant Investment LP | 88,445 | $665,000 | 0.03% |